(Q37523903)

20 August 2017

1 reference

title

Biomarkers in amyotrophic lateral sclerosis: facts and future horizons (English)

1 reference

amyotrophic lateral sclerosis

20 August 2017

0 references

0 references

author

Pierre-François Pradat

series ordinal

1

object named as

Pierre-François Pradat

1 reference

20 August 2017

Michel Dib

2

1 reference

20 August 2017

publication date

1 January 2009

1 reference

Molecular Diagnosis and Therapy

20 August 2017

published in

1 reference

20 August 2017

volume

13

1 reference

20 August 2017

issue

2

1 reference

20 August 2017

page(s)

115-125

1 reference

https://scigraph.springernature.com/pub.10.1007/bf03256320

20 August 2017

exact match

0 references

cites work

El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1007%2FBF03256320

Amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256320

TDP-43: a novel neurodegenerative proteinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256320

Electrodiagnostic criteria for diagnosis of ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256320

Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256320

Incidence of ALS in Lombardy, Italy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256320

The heterogeneity of amyotrophic lateral sclerosis: a possible explanation of treatment failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256320

Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256320

Early symptom progression rate is related to ALS outcome: a prospective population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256320

Clinical features of amyotrophic lateral sclerosis according to the El Escorial and Airlie House diagnostic criteria: A population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256320

An analysis of extended survival in patients with amyotrophic lateral sclerosis treated with riluzole

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256320

Prognostic factors for survival in amyotrophic lateral sclerosis patients treated with riluzole

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256320

Complex genetics of amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256320

TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256320

Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256320

Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256320

Genetics of sporadic amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256320

Increased lipid peroxidation in sera of ALS patients: a potential biomarker of disease burden

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256320

Glutamate levels in cerebrospinal fluid in amyotrophic lateral sclerosis: a reappraisal using a new HPLC method with coulometric detection in a large cohort of patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256320

Activity and expression of glutathione S-transferase pi in patients with amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256320

Oxidative stress and metal content in blood and cerebrospinal fluid of amyotrophic lateral sclerosis patients with and without a Cu, Zn-superoxide dismutase mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256320

An increase of oxidized coenzyme Q-10 occurs in the plasma of sporadic ALS patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256320

Activity of protein phosphatase calcineurin is decreased in sporadic and familial amyotrophic lateral sclerosispatients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256320

VEGF is increased in serum but not in spinal cord from patients with amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256320

Prostaglandin E2 is increased in amyotrophic lateral sclerosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256320

Detection of serum reverse transcriptase activity in patients with ALS and unaffected blood relatives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256320

Raised nitrate concentration and low SOD activity in the CSF of sporadic ALS patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256320

The advanced glycation end-product N epsilon-(carboxymethyl)lysine level is elevated in cerebrospinal fluid of patients with amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256320

Pigment epithelium-derived factor is elevated in CSF of patients with amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256320

Low levels of the vascular endothelial growth factor in CSF from early ALS patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256320

Intrathecal upregulation of granulocyte colony stimulating factor and its neuroprotective actions on motor neurons in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256320

Decreased cerebrospinal fluid cGMP levels in patients with amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256320

The neurite outgrowth inhibitor Nogo-A promotes denervation in an amyotrophic lateral sclerosis model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256320

Sodium valproate exerts neuroprotective effects in vivo through CREB-binding protein-dependent mechanisms but does not improve survival in an amyotrophic lateral sclerosis mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256320

Nogo provides a molecular marker for diagnosis of amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256320

The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256320

NOGO is increased and binds to BACE1 in sporadic inclusion-body myositis and in A beta PP-overexpressing cultured human muscle fibers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256320

Identification of potential CSF biomarkers in ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256320

Review neuroimaging in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256320

Diffusion tensor MRI assesses corticospinal tract damage in ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256320

Magnetic resonance imaging in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256320

MRI-FLAIR images of the head show corticospinal tract alterations in ALS patients more frequently than T2-, T1- and proton-density-weighted images

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256320

The corticospinal tract in amyotrophic lateral sclerosis: an MRI study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256320

Reduced MTR in the corticospinal tract and normal T2 in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256320

Brain and spinal cord MRI in motor neuron disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256320

MRI and clinical features in amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256320

Diffusion tensor imaging for the assessment of upper motor neuron integrity in ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256320

Assessment of disease progression in motor neuron disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256320

Diffusion anisotropy of the cervical cord is strictly associated with disability in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256320

Proton magnetic resonance spectroscopy of the motor cortex in 70 patients with amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256320

Magnetic resonance imaging and 1H-magnetic resonance spectroscopy in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256320

Early detection and longitudinal changes in amyotrophic lateral sclerosis by (1)H MRSI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256320

Quantification of brain metabolites in amyotrophic lateral sclerosis by localized proton magnetic resonance spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256320

Detection of cerebral degeneration in amyotrophic lateral sclerosis using high-field magnetic resonance spectroscopy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256320

Diffusion tensor MRI of early upper motor neuron involvement in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256320

Quantitative diffusion tensor imaging in amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256320

Diffusion tensor imaging and voxel based morphometry study in amyotrophic lateral sclerosis: relationships with motor disability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256320

Quantitative objective markers for upper and lower motor neuron dysfunction in ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256320

A longitudinal study of diffusion tensor MRI in ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256320

Amyotrophic lateral sclerosis: diffusion tensor tractography and voxel-based analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256320

Probabilistic diffusion tractography: a potential tool to assess the rate of disease progression in amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256320

Widespread sensorimotor and frontal cortical atrophy in Amyotrophic Lateral Sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256320

Serial MRI and SPECT in amyotrophic lateral sclerosis: a case report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256320

Focal reductions of cerebral blood flow in amyotrophic lateral sclerosis: a [99mTc]-d,l-HMPAO SPECT study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256320

Reduced isotope uptake restricted to the motor area in patients with amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256320

Neuroimaging in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256320

Brain perfusion imaging in amyotrophic lateral sclerosis: extent of cortical changes according to the severity and topography of motor impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256320

Cerebral glucose utilization in motor neuron disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256320

[11C]-WAY100635 PET demonstrates marked 5-HT1A receptor changes in sporadic ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256320

Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [11C](R)-PK11195 positron emission tomography study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256320

Cortical function in amyotrophic lateral sclerosis. A positron emission tomography study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256320

Pattern of cortical reorganization in amyotrophic lateral sclerosis: a functional magnetic resonance imaging study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256320

Brain metabolites in definite amyotrophic lateral sclerosis. A longitudinal proton magnetic resonance spectroscopy study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256320

Cerebrospinal fluid Flt3 ligand level in patients with amyotrophic lateral sclerosis

21 January 2018

1 reference

12 December 2020

The diagnostic interval in amyotrophic lateral sclerosis

1 reference

12 December 2020

Production of monocyte chemoattractant protein-1 in amyotrophic lateral sclerosis

1 reference

12 December 2020

Focal signal-intensity variations in the posterior internal capsule: normal MR findings and distinction from pathologic findings

1 reference

12 December 2020

Muscle Nogo-A expression is a prognostic marker in lower motor neuron syndromes

1 reference

12 December 2020

Increased serum CNTF level in patients with amyotrophic lateral sclerosis

1 reference

12 December 2020

Dyslipidemia is a protective factor in amyotrophic lateral sclerosis

1 reference

12 December 2020

Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man

1 reference

12 December 2020

Diffusion tensor imaging-based fractional anisotropy quantification in the corticospinal tract of patients with amyotrophic lateral sclerosis using a probabilistic mixture model.

1 reference

12 December 2020

Increased expression of Noga-A in ALS muscle biopsies is not unique for this disease

1 reference

12 December 2020

Transforming growth factor-Beta 1 (tgf-Beta 1) in patients with amyotrophic lateral sclerosis

1 reference

12 December 2020

Cerebrospinal fluid vascular endothelial growth factor in patients with amyotrophic lateral sclerosis

1 reference

12 December 2020

Gene profiling of skeletal muscle in an amyotrophic lateral sclerosis mouse model

1 reference

12 December 2020

[Classical and atypical clinical features in amyotrophic lateral sclerosis]

1 reference

12 December 2020

Increased plasma TGF-beta1 in patients with amyotrophic lateral sclerosis

1 reference

12 December 2020

Serum bilirubin concentration in patients with amyotrophic lateral sclerosis

1 reference

12 December 2020

APOE: a potential marker of disease progression in ALS

1 reference

12 December 2020

Detection of pyramidal tract lesions in amyotrophic lateral sclerosis with magnetization-transfer measurements.

1 reference

12 December 2020

[Differential diagnosis and atypical subsets of amyotrophic lateral sclerosis]

1 reference

12 December 2020

Cortical motor-sensory hypometabolism in amyotrophic lateral sclerosis: a PET study

1 reference

12 December 2020

Immunocytochemical characterization of neurofibrillary tangles in amyotrophic lateral sclerosis and parkinsonism-dementia of Guam

1 reference

12 December 2020

Amyotrophic lateral sclerosis: T2 shortening in motor cortex at MR imaging

1 reference

12 December 2020

Decreased serum-soluble TRAIL levels in patients with amyotrophic lateral sclerosis

1 reference

12 December 2020

Nogo expression in muscle correlates with amyotrophic lateral sclerosis severity

1 reference

12 December 2020

Detection of cortical neuron loss in motor neuron disease by proton magnetic resonance spectroscopic imaging in vivo

1 reference

12 December 2020

Amyotrophic lateral sclerosis: correlation of clinical and MR imaging findings

1 reference

12 December 2020

Spatial profiling of the corticospinal tract in amyotrophic lateral sclerosis using diffusion tensor imaging

1 reference

12 December 2020

[Clinical characteristics of amyotrophic lateral sclerosis subsets]

1 reference

12 December 2020

Decreased serum endoglin level in patients with amyotrophic lateral sclerosis: a preliminary report

1 reference

12 December 2020

Predictors of delay in the diagnosis and clinical trial entry of amyotrophic lateral sclerosis patients: a population-based study

1 reference

12 December 2020

The pro and the active form of matrix metalloproteinase-9 is increased in serum of patients with amyotrophic lateral sclerosis

1 reference

12 December 2020

Amyotrophic Lateral Sclerosis Mimic Syndromes

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03256320

1 reference

20 August 2017

1 reference